NO20025760L - S-metyl-dihydro-ziprasidon for behandling av psykiatriske og okkul¶re forstyrrelser - Google Patents

S-metyl-dihydro-ziprasidon for behandling av psykiatriske og okkul¶re forstyrrelser

Info

Publication number: NO20025760L
Authority: NO; Norway
Prior art keywords: ziprasidone; psychiatric; dihydro; methyl; treatment
Prior art date: 2000-06-02

Application number

NO20025760A

Other languages

English (en)

Other versions

NO325077B1 (no

NO20025760D0 (no

Inventor

Chandra Aggarwal Prakash

Teresa Annette Smolarek

Original Assignee

Pfizer Prod Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-06-02

Filing date

2002-11-29

Publication date

2003-01-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26903852&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20025760(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2002-11-29 Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc

2002-11-29 Publication of NO20025760D0 publication Critical patent/NO20025760D0/no

2003-01-15 Publication of NO20025760L publication Critical patent/NO20025760L/no

2008-01-28 Publication of NO325077B1 publication Critical patent/NO325077B1/no

Links

NHUDBVVEHOSVCD-UHFFFAOYSA-N 6-chloro-5-[2-[4-(2-methylsulfanylbenzenecarboximidoyl)piperazin-1-yl]ethyl]-1,3-dihydroindol-2-one Chemical compound CSC1=CC=CC=C1C(=N)N1CCN(CCC=2C(=CC=3NC(=O)CC=3C=2)Cl)CC1 NHUDBVVEHOSVCD-UHFFFAOYSA-N 0.000 title 1
208000022873 Ocular disease Diseases 0.000 title 1
208000020016 psychiatric disease Diseases 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Epidemiology (AREA)
Ophthalmology & Optometry (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Emergency Medicine (AREA)
Vascular Medicine (AREA)
Psychology (AREA)
Hospice & Palliative Care (AREA)
Urology & Nephrology (AREA)
Anesthesiology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Indole Compounds (AREA)
Hydrogenated Pyridines (AREA)
Medicinal Preparation (AREA)
Plural Heterocyclic Compounds (AREA)

NO20025760A 2000-06-02 2002-11-29 Anvendelse av S-metyl-dihydro-ziprasidon for fremstilling av et farmasoytisk preparat og en farmasoytisk blanding. NO325077B1 (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US20913600P	2000-06-02	2000-06-02
US21217200P	2000-06-16	2000-06-16
PCT/IB2001/000933 WO2001091756A2 (en)	2000-06-02	2001-05-28	S-methyl-dihydro-ziprasidone for treatment of psychiatric and ocular disorders

Publications (3)

Publication Number	Publication Date
NO20025760D0 NO20025760D0 (no)	2002-11-29
NO20025760L true NO20025760L (no)	2003-01-15
NO325077B1 NO325077B1 (no)	2008-01-28

Family

ID=26903852

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20025760A NO325077B1 (no)	2000-06-02	2002-11-29	Anvendelse av S-metyl-dihydro-ziprasidon for fremstilling av et farmasoytisk preparat og en farmasoytisk blanding.

Country Status (44)

Country	Link
US (1)	US20060287336A1 (no)
EP (3)	EP1286672B1 (no)
JP (2)	JP2003534381A (no)
KR (1)	KR20030007824A (no)
CN (1)	CN1431901A (no)
AP (2)	AP1831A (no)
AR (1)	AR028937A1 (no)
AT (3)	ATE343387T1 (no)
AU (1)	AU2001258690A1 (no)
BG (1)	BG107267A (no)
BR (1)	BR0111271A (no)
CA (1)	CA2410618A1 (no)
CY (1)	CY1105992T1 (no)
CZ (1)	CZ20023860A3 (no)
DE (3)	DE60133596D1 (no)
DK (1)	DK1468686T3 (no)
DO (1)	DOP2001000181A (no)
EA (1)	EA007068B1 (no)
EC (1)	ECSP024369A (no)
EE (1)	EE200200670A (no)
ES (1)	ES2277170T3 (no)
GE (1)	GEP20053512B (no)
HN (1)	HN2001000119A (no)
HR (1)	HRP20020953A2 (no)
HU (1)	HUP0301747A2 (no)
IL (2)	IL152782A0 (no)
IS (1)	IS6619A (no)
MA (1)	MA26908A1 (no)
MX (1)	MXPA02011862A (no)
NO (1)	NO325077B1 (no)
NZ (1)	NZ551012A (no)
OA (1)	OA12267A (no)
PA (1)	PA8518301A1 (no)
PE (1)	PE20011329A1 (no)
PL (1)	PL365576A1 (no)
PT (2)	PT1468686E (no)
SI (1)	SI1468686T1 (no)
SK (1)	SK16622002A3 (no)
SV (1)	SV2002000473A (no)
UA (1)	UA79425C2 (no)
UY (1)	UY26742A1 (no)
WO (1)	WO2001091756A2 (no)
YU (1)	YU90702A (no)
ZA (1)	ZA200209665B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2003296991A1 (en)	2002-12-13	2004-07-09	Regents Of The University Of Minnesota	Scleral depressor
CA2543805A1 (en)	2003-10-24	2005-05-06	Gideon Pilarsky	Processes for preparation of ziprasidone
ES2250001B1 (es) *	2004-09-29	2007-06-01	Medichem, S.A.	Proceso para la purificacion de ziprasidona.
JP2012174228A (ja) *	2011-02-24	2012-09-10	Kyocera Corp	プログラム保護装置および通信装置
WO2014078568A1 (en)	2012-11-14	2014-05-22	The Johns Hopkins University	Methods and compositions for treating schizophrenia
US9981041B2 (en) *	2016-08-23	2018-05-29	Ira Jason Salzman	Ophthalmic lubricating spray

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL126590A (en) *	1996-05-07	2001-11-25	Pfizer	Trihydrate salt of -5 (-2 (-4 (1 (2, 2-benzothiazole - 3yl) -1-piperazinyl) ethyl) - 6-chloro-1, 3-dihydro-2 (1H) - indole - 2On (= Ziprasidone) and pharmaceutical preparations containing it
TW491847B (en) *	1996-05-07	2002-06-21	Pfizer	Mesylate dihydrate salts of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2h-indol-2-one
ES2204067T3 (es) *	1998-05-26	2004-04-16	Pfizer Products Inc.	Medicamento para el tratamiento del glaucoma y de la retinopatia isquemica.
EP1165083A2 (en) *	1999-04-06	2002-01-02	Sepracor Inc.	Methods and compositions for the treatment of psychotic and related disorders using ziprasidone metabolites

2001
- 2001-05-28 AU AU2001258690A patent/AU2001258690A1/en not_active Abandoned
- 2001-05-28 WO PCT/IB2001/000933 patent/WO2001091756A2/en not_active Ceased
- 2001-05-28 MX MXPA02011862A patent/MXPA02011862A/es active IP Right Grant
- 2001-05-28 UA UA2002119557A patent/UA79425C2/uk unknown
- 2001-05-28 KR KR1020027016364A patent/KR20030007824A/ko not_active Ceased
- 2001-05-28 JP JP2001587771A patent/JP2003534381A/ja not_active Withdrawn
- 2001-05-28 ES ES04013380T patent/ES2277170T3/es not_active Expired - Lifetime
- 2001-05-28 SI SI200130681T patent/SI1468686T1/sl unknown
- 2001-05-28 DE DE60133596T patent/DE60133596D1/de not_active Expired - Lifetime
- 2001-05-28 PT PT04013380T patent/PT1468686E/pt unknown
- 2001-05-28 GE GE4972A patent/GEP20053512B/en unknown
- 2001-05-28 EP EP01932011A patent/EP1286672B1/en not_active Expired - Lifetime
- 2001-05-28 PT PT06116051T patent/PT1698338E/pt unknown
- 2001-05-28 PL PL01365576A patent/PL365576A1/xx unknown
- 2001-05-28 IL IL15278201A patent/IL152782A0/xx active IP Right Grant
- 2001-05-28 EE EEP200200670A patent/EE200200670A/xx unknown
- 2001-05-28 SK SK1662-2002A patent/SK16622002A3/sk not_active Application Discontinuation
- 2001-05-28 DE DE60124791T patent/DE60124791T2/de not_active Expired - Fee Related
- 2001-05-28 CN CN01810620A patent/CN1431901A/zh active Pending
- 2001-05-28 EP EP06116051A patent/EP1698338B1/en not_active Expired - Lifetime
- 2001-05-28 EP EP04013380A patent/EP1468686B1/en not_active Expired - Lifetime
- 2001-05-28 OA OA1200200349A patent/OA12267A/en unknown
- 2001-05-28 AT AT01932011T patent/ATE343387T1/de not_active IP Right Cessation
- 2001-05-28 BR BR0111271-6A patent/BR0111271A/pt not_active Application Discontinuation
- 2001-05-28 DK DK04013380T patent/DK1468686T3/da active
- 2001-05-28 NZ NZ551012A patent/NZ551012A/en unknown
- 2001-05-28 AT AT06116051T patent/ATE391507T1/de not_active IP Right Cessation
- 2001-05-28 HR HR20020953A patent/HRP20020953A2/hr not_active Application Discontinuation
- 2001-05-28 CA CA002410618A patent/CA2410618A1/en not_active Abandoned
- 2001-05-28 AT AT04013380T patent/ATE345818T1/de not_active IP Right Cessation
- 2001-05-28 CZ CZ20023860A patent/CZ20023860A3/cs unknown
- 2001-05-28 EA EA200201168A patent/EA007068B1/ru not_active IP Right Cessation
- 2001-05-28 YU YU90702A patent/YU90702A/sh unknown
- 2001-05-28 DE DE60124093T patent/DE60124093D1/de not_active Expired - Lifetime
- 2001-05-28 HU HU0301747A patent/HUP0301747A2/hu unknown
- 2001-05-31 DO DO2001000181A patent/DOP2001000181A/es unknown
- 2001-05-31 UY UY26742A patent/UY26742A1/es not_active Application Discontinuation
- 2001-05-31 AP APAP/P/2001/002180A patent/AP1831A/en active
- 2001-05-31 HN HN2001000119A patent/HN2001000119A/es unknown
- 2001-05-31 PE PE2001000504A patent/PE20011329A1/es not_active Application Discontinuation
- 2001-05-31 AP AP2005003272A patent/AP1747A/xx active
- 2001-06-01 PA PA20018518301A patent/PA8518301A1/es unknown
- 2001-06-01 AR ARP010102641A patent/AR028937A1/es unknown
- 2001-06-01 SV SV2001000473A patent/SV2002000473A/es not_active Application Discontinuation
- 2001-06-04 US US09/873,973 patent/US20060287336A1/en not_active Abandoned
2002
- 2002-11-11 IL IL152782A patent/IL152782A/en not_active IP Right Cessation
- 2002-11-12 BG BG107267A patent/BG107267A/bg unknown
- 2002-11-14 IS IS6619A patent/IS6619A/is unknown
- 2002-11-28 ZA ZA200209665A patent/ZA200209665B/en unknown
- 2002-11-29 MA MA26927A patent/MA26908A1/fr unknown
- 2002-11-29 NO NO20025760A patent/NO325077B1/no unknown
- 2002-11-29 EC EC2002004369A patent/ECSP024369A/es unknown
2007
- 2007-02-08 CY CY20071100161T patent/CY1105992T1/el unknown
- 2007-11-14 JP JP2007296039A patent/JP2008056700A/ja not_active Withdrawn

Also Published As

Publication number	Publication date
WO2001091756A2 (en)	2001-12-06
DK1468686T3 (da)	2007-03-12
PT1468686E (pt)	2007-01-31
PL365576A1 (en)	2005-01-10
EP1698338B1 (en)	2008-04-09
CZ20023860A3 (cs)	2004-01-14
PE20011329A1 (es)	2002-01-15
NO325077B1 (no)	2008-01-28
DE60124093D1 (de)	2006-12-07
EA200201168A1 (ru)	2003-06-26
PA8518301A1 (es)	2002-09-17
MA26908A1 (fr)	2004-12-20
AP1747A (en)	2007-05-31
HUP0301747A2 (hu)	2003-09-29
MXPA02011862A (es)	2003-04-10
ATE391507T1 (de)	2008-04-15
CY1105992T1 (el)	2011-04-06
PT1698338E (pt)	2008-06-03
EP1286672A2 (en)	2003-03-05
IS6619A (is)	2002-11-14
GEP20053512B (en)	2005-05-10
BG107267A (bg)	2003-06-30
ZA200209665B (en)	2003-11-28
DOP2001000181A (es)	2002-04-15
CN1431901A (zh)	2003-07-23
SK16622002A3 (sk)	2004-07-07
IL152782A0 (en)	2003-06-24
JP2008056700A (ja)	2008-03-13
UY26742A1 (es)	2001-12-28
CA2410618A1 (en)	2001-12-06
US20060287336A1 (en)	2006-12-21
EP1468686B1 (en)	2006-11-22
KR20030007824A (ko)	2003-01-23
JP2003534381A (ja)	2003-11-18
AP1831A (en)	2008-02-26
AP2005003272A0 (en)	2005-03-31
OA12267A (en)	2004-01-20
NZ551012A (en)	2008-04-30
YU90702A (sh)	2005-11-28
NO20025760D0 (no)	2002-11-29
ES2277170T3 (es)	2007-07-01
EP1468686A3 (en)	2004-12-01
ATE345818T1 (de)	2006-12-15
ATE343387T1 (de)	2006-11-15
HN2001000119A (es)	2001-09-11
ECSP024369A (es)	2003-02-06
IL152782A (en)	2007-10-31
EP1468686A2 (en)	2004-10-20
DE60124791D1 (de)	2007-01-04
AR028937A1 (es)	2003-05-28
AU2001258690A1 (en)	2001-12-11
EA007068B1 (ru)	2006-06-30
DE60124791T2 (de)	2007-09-13
DE60133596D1 (de)	2008-05-21
EE200200670A (et)	2004-08-16
EP1286672B1 (en)	2006-10-25
EP1698338A3 (en)	2006-09-20
WO2001091756A3 (en)	2002-09-26
SI1468686T1 (sl)	2007-04-30
UA79425C2 (en)	2007-06-25
EP1698338A2 (en)	2006-09-06
BR0111271A (pt)	2003-06-10
HRP20020953A2 (en)	2005-02-28
SV2002000473A (es)	2002-10-24

Publication	Publication Date	Title
NO20026008D0 (no)	2002-12-13	Fremgangsmåte for behandling av cardiovaskul¶re sykdommer
GB0007193D0 (en)	2000-05-17	Treatment of movrmrnt disorders
NO20026263L (no)	2002-12-27	Sulfonyl-pyrrolidin-derivater anvendelige for behandling av neurologiske forstyrrelser
DE60226702D1 (de)	2008-07-03	Lang wirkendes glucagon-ähnliches peptid-2 für die behandlung von gastrointestinalen krankheiten und störungen
IS5085A (is)	1999-12-23	Nefholssamsetningar til meðhöndlunar á kynferðistruflunum
NO20032636D0 (no)	2003-06-11	3-indolinderivater som er nyttige i behandlingen av psykiatriske og nevrologiske forstyrrelser
NO20021845D0 (no)	2002-04-19	Behandling av sövnforstyrrelser under anvendelse av desloratadin
NO20043085L (no)	2004-07-13	Fremgangsmater og sammensetninger for behandling av forstyrrelser i sentralnervesystemet
DE50014041D1 (de)	2007-03-22	Verwendung von epinastin zur behandlung von allergischer rhinitis/konjunktivitis
NO20024775D0 (no)	2002-10-03	Hydroksyfenyl-piperidin-4-yliden-metyl-benzamidderivater til behandling av smerte
IL155589A0 (en)	2003-11-23	Novel amidoalkyl-piperidine and amidoalkyl-piperazine derivatives useful for the treatment of nervous system disorders
DK1165510T3 (da)	2006-02-06	1-arensulfonyl-2-aryl-pyrrolidin- og -piperidinderivater til behandling af CNS-lidelser
PL367959A1 (en)	2005-03-07	Integrin inhibitors for the treatment of eye diseases
ID27214A (id)	2001-03-08	Triazolopiridina untuk pengobatan gangguan trombosis
NO20023448L (no)	2002-09-17	Medikamentkombinasjon for behandling av depresjon og beslektede forstyrrelser omfattende mirtazapin
NO20024776D0 (no)	2002-10-03	Hydroksyfenyl-piperazinyl-metyl-benzamidderivater til behandling av smerte
NO20024777L (no)	2002-12-03	Kinolinyl-piperidin-4-yliden-metyl-benzamid derivater til behandling av smerte
NO20025760D0 (no)	2002-11-29	S-metyl-dihydro-ziprasidon for behandling av psykiatriske og okkul¶re forstyrrelser
NO20023803D0 (no)	2002-08-09	Anvendelse av mirtazapin for behandling av sövnforstyrrelser
NO20032156L (no)	2003-05-13	Behandling av angstforstyrrelser
AR026062A1 (es)	2002-12-26	Tratamiento de desordenes oculares
NO20035043D0 (no)	2003-11-13	Fremgangsmåte for behandling av okular hypertensjon og glaukom
NO20012612D0 (no)	2001-05-28	Isonipecotamider for behandling av integren-formidlede lidelser
NO20010390D0 (no)	2001-01-23	Behandling av angstsykdommer
NO20030717L (no)	2003-02-14	Forbindelser for behandling av avhengighetsforstyrrelser